Polio

n-Lorem Foundation Appoints Claire Grezemkovsky as Director of Philanthropy

Retrieved on: 
Monday, June 7, 2021

n-Lorem Foundation , a nonprofit organization providing the ultra-rare disease patients with free, lifetime supplies of individualized RNA-targeted medicines, today announced the appointment of Claire Grezemkovsky as its first-ever Director of Philanthropy.

Key Points: 
  • n-Lorem Foundation , a nonprofit organization providing the ultra-rare disease patients with free, lifetime supplies of individualized RNA-targeted medicines, today announced the appointment of Claire Grezemkovsky as its first-ever Director of Philanthropy.
  • Grezemkovsky joins the n-Lorem team with over 10 years of experience in corporate and foundation relations, working with notable organizations such as the Salk Institute for Biological Studies, W.M.
  • With Claire Grezemkovsky joining our team, our efforts to provide rapid hope and treat more patients in desperate need becomes even more achievable, said Dr. Stanley T. Crooke, Founder, CEO and Chairman, n-Lorem Foundation.
  • Before starting her career in philanthropy, Grezemkovsky worked as an academic researcher and instructor at the University of California, Berkley.

PharmaJet: The Lancet Publication Confirms Viability of Intradermal Polio Vaccination

Retrieved on: 
Thursday, June 3, 2021

Intradermal fractional dose delivery also lowers the total cost of vaccination substantially.

Key Points: 
  • Intradermal fractional dose delivery also lowers the total cost of vaccination substantially.
  • Intradermal delivery with needle and syringe is difficult for mass vaccination campaigns as it requires significant training to master, resulting in inconsistent results.
  • It requires minimal training, and virtually eliminates vaccine wastage, making it an excellent tool for mass vaccination campaigns and routine use.
  • It is ideal for delivery of intradermal polio vaccinations given its consistency and the improved immune response of 2 fractional ID doses versus 1 full intramuscular dose.

TELUS Tech for Good program expands across Canada to help connect and empower Canadians with disabilities

Retrieved on: 
Monday, May 31, 2021

Tech for Good enables equitable access to mobile devices, empowering people with disabilities to live, work, and play in our digital world.

Key Points: 
  • Tech for Good enables equitable access to mobile devices, empowering people with disabilities to live, work, and play in our digital world.
  • Through our Tech for Good program, and in collaboration with March of Dimes Canada, the TELUS team is passionate about deploying our technology brilliantly to empower Canadians of all abilities to prosper in our digital world.
  • The Tech for Good program provides people with disabilities direct access to Assistive Technologists at March of Dimes Canada who have specialized knowledge about accessibility barriers and assistive technologies for mobile devices.
  • As a national charity devoted to supporting and empowering people living with disability, the Tech for Good program is a perfect fit.

Immunization services begin slow recovery from COVID-19 disruptions, though millions of children remain at risk from deadly diseases - UNICEF

Retrieved on: 
Monday, April 26, 2021

According to new data, 60 of these lifesaving campaigns are currently postponed in 50 countries, putting around 228 million people - mostly children - at risk for diseases such as measles, yellow fever and polio.

Key Points: 
  • According to new data, 60 of these lifesaving campaigns are currently postponed in 50 countries, putting around 228 million people - mostly children - at risk for diseases such as measles, yellow fever and polio.
  • Measles campaigns account for 23 of the postponed campaigns, affecting an estimated 140 million people.
  • "We must sustain this energyon vaccine roll-outtoalsohelp childrencatch up on their measles, polio and other vaccines.
  • This year\'s theme, \'Vaccines bring us closer,\' aims to show how vaccination connects us to the people, goals and moments that matter, helping improve the health of everyone, everywhere throughout life.\n'

March of Dimes Announces Second Annual It Starts With Mom Campaign Focused on Maternal Health & Wellness

Retrieved on: 
Monday, April 26, 2021

"\nIn addition to the resources on the website, the second annual It Starts With Mom Live will take place on May 7 at 2:00 p.m.

Key Points: 
  • "\nIn addition to the resources on the website, the second annual It Starts With Mom Live will take place on May 7 at 2:00 p.m.
  • "\nMarch of Dimes is partnering with Macy\'s , The Honest Company , EMD Serono , Nuk , Clearblue , Medela , PARENTS and PARENTS LATINA for the It Starts With Mom campaign.
  • Health and wellness information related to pre-pregnancy, pregnancy, and post-partum care is available at ItStartsWithMom.org .\nMarch of Dimes leads the fight for the health of all moms and babies.
  • Building on a successful 80-year legacy of impact and innovation, we empower every mom and every family.\nView original content to download multimedia: http://www.prnewswire.com/news-releases/march-of-dimes-announces-second-...\nSOURCE March of Dimes Inc.\n'

Istari Oncology Announces FDA Clearance of IND to Initiate LUMINOS-103: A Basket Trial Evaluating the Safety and Efficacy for PVSRIPO in Patients with Advanced Solid Tumors

Retrieved on: 
Monday, April 19, 2021

LUMINOS-103 ( NCT04690699 ) is a Phase 1/2 open-label, multi-center, single-arm basket trial evaluating the administration of PVSRIPO with or without PD-1/L1 inhibitors in adult subjects with solid tumor cancers.

Key Points: 
  • LUMINOS-103 ( NCT04690699 ) is a Phase 1/2 open-label, multi-center, single-arm basket trial evaluating the administration of PVSRIPO with or without PD-1/L1 inhibitors in adult subjects with solid tumor cancers.
  • PVSRIPO enters solid tumor cells and antigen presenting cells (APCs) in the tumor microenvironment via CD155 (the poliovirus receptor).
  • "If the tumor can be biopsied, it can be injected, so there are a wide range of solid tumors we can investigate with PVSRIPO.
  • PVSRIPO has a distinct point of entry (the poliovirus receptor, CD155), which is expressed on virtually all solid tumors and antigen-presenting cells.

March of Dimes 'Step Up Challenge' Aims to Raise Critical Funds for March for Babies: A Mother of a Movement™

Retrieved on: 
Thursday, April 8, 2021

To support the effort, March of Dimes launched the March of Dimes Charity Cloudapp where users can set up and track their steps, as well as their fundraising goals.

Key Points: 
  • To support the effort, March of Dimes launched the March of Dimes Charity Cloudapp where users can set up and track their steps, as well as their fundraising goals.
  • "We're grateful to all our supporters who have already stepped up and encourage those who haven't to download the app today and get started.
  • After joining the challenge, look for different ways to engage in our mission and support moms and babies now through June.
  • March of Dimes thanks its national partners, HCA Healthcare and Reckitt, both longtime supporters in our fight for the health of all moms and babies.

The Honest Company Partners with March of Dimes to Help Support Initiatives Supporting Environmental Justice for Moms and Babies

Retrieved on: 
Wednesday, April 7, 2021

Through this partnership, Honest will donate $250,000 to support the organization, including its new Mom and Baby Action Network.

Key Points: 
  • Through this partnership, Honest will donate $250,000 to support the organization, including its new Mom and Baby Action Network.
  • In the world we live in today, moms are faced with more challenges than ever as they prepare to welcome children into this world, said The Honest Company Founder, Jessica Alba.
  • Through this collaboration, The Honest Company will act as a liaison on consumer education and advocacy opportunities.
  • This is the second year in a row The Honest Company has partnered with March of Dimes in honor of Mothers Day.

Mexico, Direct Relief Deliver 650,000 Polio Vaccine Doses to Nicaragua

Retrieved on: 
Thursday, April 1, 2021

MEXICO CITY, April 1, 2021 /PRNewswire/ -- Direct Relief, working with the Mexican Ministry of Foreign Affairs, BIRMEX, and the Nicaragua Ministry of Health (MINSA), transported this week 650,000 doses of the polio vaccine to Nicaragua to bolster the nation's child vaccination efforts.

Key Points: 
  • MEXICO CITY, April 1, 2021 /PRNewswire/ -- Direct Relief, working with the Mexican Ministry of Foreign Affairs, BIRMEX, and the Nicaragua Ministry of Health (MINSA), transported this week 650,000 doses of the polio vaccine to Nicaragua to bolster the nation's child vaccination efforts.
  • The supplies were delivered via a Direct Relief-chartered AeroMexico flight from Mexico City to Managua on Wednesday.
  • Earlier this month, Direct Relief, a registered civil association in Mexico with tax-deductible status, worked with the Government of Mexico to transport 95,000 doses of bivalent oral polio vaccine to Ecuador .
  • Direct Relief has extensive experience working with the world's largest medical manufacturers to distribute cold-chain prescription medications connected with humanitarian and emergency-response efforts.

Mexico's Government, Direct Relief Transport Polio Vaccine to Ecuador in Response to International Appeal

Retrieved on: 
Wednesday, March 17, 2021

Ecuador last month launched a national campaign to inoculate infants against polio, but it ran short of the vaccine doses needed.

Key Points: 
  • Ecuador last month launched a national campaign to inoculate infants against polio, but it ran short of the vaccine doses needed.
  • Ecuador's Ministry of Public Health issued an international appeal for polio vaccine to organizations including Direct Relief and nations including Mexico.
  • Ecuador requested 95,000 doses of the polio vaccine and 138,000 doses of other vaccines commonly given to children.
  • The Government of Mexico responded to the appeal, offering to donate the polio vaccine from its stockpile at the national vaccine agency BIRMEX.